Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149
Clinical trial NCT03997448 · TERMINATED
Trial details
- NCT number
- NCT03997448
- Sponsor
- Nataliya Uboha
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-26
- Primary completion
- 2020-01-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.